Verapamili hydrochloridum, Trandolaprilum

Medicinal product name Tarka 240 mg/4 mg modified-release tablets
Pharmaceutical form Modified-release tablet
Strength 240 mg/4 mg 
Information from the MAH on shortages Not available
predicted availability date: not notified
Legal status Rx Prescription (Pr.)
Package leaflet MS Word document 28-01-2021
Summary of product characteristics MS Word document 28-01-2021
ATC code C08DA51 Calcium channel blockers

Medicinal products (6)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers)
predicted availability date: not notified
currently no information on availability from any wholesaler N28
(240 mg/4 mg)
PVC/PVDC/Al blister    09-0157-01 Labelling text Labelling text Aug 8, 2019
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N30
(240 mg/4 mg)
PVC/PVDC/Al blister    09-0157-02 Labelling text Labelling text Aug 8, 2019
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N50
(240 mg/4 mg)
PVC/PVDC/Al blister    09-0157-03 Labelling text Labelling text Aug 8, 2019
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N56
(240 mg/4 mg)
PVC/PVDC/Al blister    09-0157-04 Labelling text Labelling text Aug 8, 2019
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N98
(240 mg/4 mg)
PVC/PVDC/Al blister    09-0157-05 Labelling text Labelling text Aug 8, 2019
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N280
(240 mg/4 mg)
PVC/PVDC/Al blister    09-0157-06 Labelling text Labelling text Aug 8, 2019

Registration information

Marketing authorisation No. 09-0157
Date of authorisation Apr 30, 2009
MA valid until For unlimited time
Marketing authorisation holder, country Mylan Healthcare, SIA, Latvia